Company page

Ipsen Sa

Ipsen Sa is a public company listed on the French market under the ticker IPN, with a market capitalization of approximately €14.64 billion. The company specializes in biopharmaceuticals, focusing on innovative medicines in areas such as oncology, neuroscience, and rare diseases. Ipsen is committed to improving patient outcomes through its research and development efforts.